Fusion Biotechnology
PrivateLast Round
Grant
Mar 18, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Fusion Biotechnology operates in Healthcare & Life Sciences and is based in Ulsan. Its latest recorded funding round was a Grant round in March 2026.
Fusion Biotechnology is a biotechnology company that develops chemical and biological drugs for degenerative and intractable diseases using a proprietary protein-substrate docking platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fusion Biotechnology Comparables
Compare Fusion Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cleara Biotech | 80% | |
| Oisín Biotechnologies | 78% | |
| Rubedo Life Sciences | 77% |
For institutional investors. Book with your work email.
Fusion Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 18, 2026 | ||||
| Grant | Oct 18, 2025 | ||||
| Grant | Nov 28, 2024 | ||||
| Grant | Jul 16, 2022 |
For institutional investors. Book with your work email.
Fusion Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ministry of Science and ICT of South Korea | Grant |
| National Research Foundation of Korea | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
Received funding from Korea Health Industry Development Institute and National Research Foundation of Korea.
- Oct 18, 2025
Received funding from Korea Institute of Science and Technology and Ministry of Science and ICT.
For institutional investors. Book with your work email.
Fusion Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fusion Biotechnology's valuation, stock price, and market status.
Is Fusion Biotechnology a public or private company?
Fusion Biotechnology is a private company.
What is the current stock price of Fusion Biotechnology?
Fusion Biotechnology is a private company, so its shares have no public market price. Caplight tracks Fusion Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fusion Biotechnology worth (valuation)?
Valuation information for Fusion Biotechnology is not publicly available.
Can I buy Fusion Biotechnology stock?
Fusion Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fusion Biotechnology's last funding round?
Fusion Biotechnology's most recent funding round was Grant on March 18, 2026.
Who are the main investors in Fusion Biotechnology?
Key investors in Fusion Biotechnology include Ministry of Science and ICT of South Korea, National Research Foundation of Korea.
Will Fusion Biotechnology IPO soon?
No public IPO plans have been announced for Fusion Biotechnology.
How can I track Fusion Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Fusion Biotechnology's shares on secondary markets.